Watch the complete recording of Peter Libby, Manfredi Rizzo and Viviane Z. Rocha as they present the highlights of IAS' clinical proceedings white paper, "Unmet Needs and the Evolving Landscape of Primary Prevention in Atherosclerosis," and discuss the value and challenge of primary prevention.
This is IAS guidance's core implementation strategies to assist with the adoption of clinical recommendations into routine practice for at-risk patients and families worldwide.
Persistent chylomicronemia is defined by high plasma triglycerides on several occasions that is unresponsive to conventional treatments.
Watch the first episode of IAS’ new Leading Insights series to hear Prof. Raul Santos and Prof. Gerald Watts discuss the PALISADE study’s findings, noting how plozasiran demonstrated it can meet the treatment gap for patients with familial chylomicronemia syndrome whether the rare disease is clinically defined or genetically confirmed. IAS received an unrestricted grant from Arrowhead […]
This paper presents a summary of primary prevention measures for atherosclerotic cardiovascular disease caused by elevated low-density lipoprotein cholesterol, and other cardio-metabolic risk factors such as obesity and diabetes, as well as hypertension
Serie de videos en español con especialistas en ASCVD para discusión sobre el riesgo cardiovascular en América Latina.
The IAS e-Newsletter is a digest of the latest from the IAS and its Constituent Member Societies.
Going beyond statins, this resource provides the latest information about primary prevention for clinicians.
